Physician

Allen C Ho, MD

According to 2025 Medicare claims, Allen Ho, MD (NPI: 1922056712) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 19006-6311.

Ho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,505 traditional Medicare patients, billed 45,314 HCPCS/CPT codes, and received $6,764,021 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 736 prescription claims across 204 beneficiaries totaling $46,881 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 36 records totaling $116,017. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $112,410 to $46,881. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7M$7.4M2015 Medicare payment: $6,979,899 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $6,649,128 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $7,006,003 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,925,337 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,976,431 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,642,131 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,394,370 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,906,074 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,432,810 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,764,021 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,99430,031$6,979,899
20161,92325,862$6,649,128
20171,99426,275$7,006,003
20182,07931,285$6,925,337
20191,92329,818$6,976,431
20201,62727,749$6,642,131
20211,77131,212$7,394,370
20221,84033,746$6,906,074
20231,62243,987$6,432,810
20241,50545,314$6,764,021

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$56K$112K2015 Drug cost: $112,410 (USD; Tot_Drug_Cst)2016 Drug cost: $103,044 (USD; Tot_Drug_Cst)2017 Drug cost: $97,464 (USD; Tot_Drug_Cst)2018 Drug cost: $98,657 (USD; Tot_Drug_Cst)2019 Drug cost: $90,761 (USD; Tot_Drug_Cst)2020 Drug cost: $57,494 (USD; Tot_Drug_Cst)2021 Drug cost: $67,052 (USD; Tot_Drug_Cst)2022 Drug cost: $63,701 (USD; Tot_Drug_Cst)2023 Drug cost: $56,242 (USD; Tot_Drug_Cst)2024 Drug cost: $46,881 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015226775$112,410
2016201668$103,044
2017229855$97,464
2018193743$98,657
2019196724$90,761
2020193707$57,494
2021244896$67,052
2022233884$63,701
2023203773$56,242
2024204736$46,881

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3774,850$659
67028Injection of drug into eye6333,597$111
92014Established patient complete exam of visual system726853$97
92012Established patient problem focused exam of visual system8162,568$70
92134Imaging of retina1,4464,858$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1998,120$11,021
ProlensaBromfenac Sodium17480$5,966
Ketorolac TromethamineKetorolac Tromethamine2105,639$4,826
Brimonidine TartrateBrimonidine Tartrate191,144$2,123
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat503,370$920

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$29,699Alcon Research LLC
Research PaymentsReported research-related payment or transfer-of-value amount.7$86,318Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Allen C. Ho, MD?

Tedicare shows public-source Medicare data for Allen C. Ho, MD (NPI 1922056712), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allen C. Ho, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Allen C. Ho, MD?

Allen C. Ho, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Allen C. Ho, MD have Open Payments data?

Allen C. Ho, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.